In Biggest-Ever Israeli Biotech Exit, Medtronic Buys Mazor for $1.6B

Irish-US firm vows to continue development of Israeli robotics technology that helps surgeons perform safer and more accurate surgeries.

READ ARTICLE by Times of Israel Staff. Published by The Times of Israel, September 21, 2018

A back surgeon looks at a 3D model of a patient's spinal column in preparation for surgery using the Mazor Renaissance system (Courtesy)

Israel Investment Fund Group, LLC

8950 W Olympic Blvd, Ste 377

Beverly Hills, CA  90211


Send Us a Message

© Israel Investment Fund Group, LLC